Pressure Biosciences (PBIO)
OTHER OTC:PBIO
US Market
Holding PBIO?
Track your performance easily

Pressure Biosciences (PBIO) Financial Statements

61 Followers

Pressure Biosciences Financial Overview

Pressure Biosciences's market cap is currently ―. The company's EPS TTM is $-1.375; its P/E ratio is -0.01; Pressure Biosciences is scheduled to report earnings on November 19, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 349.26K$ 312.35K$ 413.01K$ 511.80K$ 740.60K
Gross Profit$ 115.95K$ -21.17K$ 183.55K$ 255.20K$ 381.97K
EBIT$ -2.69M-$ -1.29M$ -1.04M$ -2.96M
EBITDA$ -2.61M-$ -1.26M$ -1.01M$ -2.94M
Net Income Common Stockholders$ -8.71M$ -10.54M$ -6.26M$ -11.11M$ -7.29M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.22K$ 81.28K$ 5.26K$ 24.98K$ 239.02K
Total Assets$ 6.99M$ 1.05M$ 1.60M$ 1.68M$ 2.21M
Total Debt$ 26.42M$ 22.24M$ 20.55M$ 18.78M$ 19.25M
Net Debt$ 26.41M$ 22.16M$ 20.55M$ 18.76M$ 19.01M
Total Liabilities$ 45.12M$ 32.16M$ 30.20M$ 26.79M$ 34.66M
Stockholders Equity$ -38.13M$ -31.75M$ -28.60M$ -25.12M$ -32.45M
Cash Flow-
Free Cash Flow$ -1.86M-$ -736.93K$ -899.17K$ -425.21K
Operating Cash Flow$ -1.86M$ -1.13M$ -732.44K$ -899.17K$ -422.21K
Investing Cash Flow--$ -4.50K-$ -3.00K
Financing Cash Flow$ 1.78M$ 1.21M$ 717.22K$ 685.13K$ 660.37K
Currency in USD

Pressure Biosciences Earnings and Revenue History

Pressure Biosciences Debt to Assets

Pressure Biosciences Cash Flow

Pressure Biosciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis